DC Investments Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,167
Closed -$201K 72
2021
Q4
$201K Buy
+2,167
New +$143K 0.29% 53
2020
Q3
Sell
-5,956
Closed -$375K 318
2020
Q2
$375K Buy
+5,956
New +$328K 0.14% 108

DC Investments Management's ARNA Position: Q1 2022 in Review

DC Investments Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 2,167 shares — an estimated $201K sold.

DC Investments Management first reported a position in ARNA in Q2 2020 and held it in 2 quarters. The position peaked at $375K in Q2 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

  • DC Investments Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
  • DC Investments Management sold 2,167 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $201K.
  • DC Investments Management first reported a position in Arena Pharmaceuticals Inc in Q2 2020 and held it in 2 quarters.
  • DC Investments Management's Arena Pharmaceuticals Inc position peaked at $375K in Q2 2020.
  • 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on DC Investments Management's 13F filing for Q1 2022, filed 13 May 2022.